Exabis Library
Welcome to the e-CCO Library!
P038: Revised roles of matrix metalloproteinase/MMP-9 in inflammatory bowel diseases: from target to biomarker
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P038: Targeting the hepcidin-ferroportin axis with Nrf2 agonists to treat iron deficiency anaemia in Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P038: Th17 cells dominate the colonic mucosal immune response in primary sclerosing cholangitis associated colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P038: Tissue differences in the pro-inflammatory activation of ER stress of patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P039 Regional distribution of TCR Vδ1 and TCR Vδ2 cells in healthy and inflamed mucosa of inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P039: Expression of the liver homing receptor CXCR3+ on colonic CD8+ T lymphocytes in patients with primary sclerosing cholangitis provides a possible link between colonic and biliary duct inflammation.
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P039: New molecular markers of the development of ulcerative colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P039: Suppression of phospholipase A2 of intestinal microbiota by the phospholipid-bile acid conjugate ursodeoxycholate-lysophoshatidylethanolamide ameliorates mucosal inflammation in a genetic mouse model of ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P039: The disappearance of cell death brakes in inflammatory bowel disease: a step towards molecular healing
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P039: The role of α4β7+CLA+ ‘dual tropic’ T cells in inflammatory bowel disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P039: Tracking intestinal epithelial cells with fluorescent dyes
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P040 Proteomic characterisation of serum extracellular vesicles in patients with inflammatory bowel diseases: a novel approach for biomarker discovery
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P040: Caspase-8 blockade attenuates NSAID-induced colitis and cell death via NLRP3 inflammasome and NF-κB activation
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P040: Intestinal EP4 receptor is required for homeostasis of the colon in mice
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P040: Paeoniflorin attenuates ulcerative colitis by inhibiting dendritic cells maturity and Th17/Treg differentiation in naive CD4+ T cells and TNBS-induced Colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P040: Reduced serological response to COVID-19 vaccines in patients with IBD is further diminished by TNF inhibitor therapy; Early results of the VARIATION study (VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON)
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P040: Sonic hedgehog inhibitor prevented colitis-associated cancer via concerted mechanisms of IL-6/gp130 inhibition, 15-prostaglandin dehydrogenase induction, Bcl-2 abrogation, and tumour sphere inhibition
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P040: The cytokine milieu in patients with inflammatory bowel disease impacts the phenotype of mesenchymal stromal cells
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P040: USP16 regulates p65 activation in macrophages and promotes the inflammatory-carcinoma transformation process in IBD patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM